TRUPCR® NPM1 MUTATION QUANTITATIVE KIT

NPM1 Mutation Quantitative

TRUPCR® NPM1 Mutation Quantitative Kit is an in-vitro nucleic acid amplification assay for the qualitative detection and quantification of NPM1 mutant allelic burden in clinical samples.
In this assay, extracted RNA is subjected to a separate real-time reverse transcription-polymerase chain reaction (RT-PCR) procedures to detect and quantitate NPM1 mutations (mutA, mutB and mutD) in exon 12 by real- time PCR. An additional amplification for the ABL1 gene is performed as a control for sample RNA quality and as a reference for relative quantification.



Three types of NPM1 mutation variants quantified by this kit are given below:

  • NPM1 mutation A (c.860_863dupTCTG),
  • NPM1 mutation B (c.863_864insCATG),
  • NPM1 mutation D (c.863_864insCCTG

Key Features:

  •  Reliable and sensitive detection and differentiation of NPM1 A, B and D mutations.
  •  Reliable and specific quantification of NPM1 A, B, and D mutations
  •  The kit offers sensitivity to detect up to 50 copies of mutant transcripts.
  •  All the reagents for cDNA chemistry and Real-time PCR are included in the kit
  •  It is compatible with various Real Time PCR instruments.
  •  Easy-to-use, rapid, reliable, comprehensive and cost-effective tests.
NPM1 Mutation Quantitative

Ordering Information:

CAT. NO. PRODUCT CONTENTS
3B325 TRUPCR® NPM1 Mutation Quantitative Kit 24 Reactions
3B326 TRUPCR® NPM1 Mutation Quantitative Kit 48 Reactions

Publications:

Deka, Riju Rani, et al. "FLT3-ITD mutation does not influence survival outcome in adult acute promyelocytic leukemia patients treated with ATO and ATRA-based therapeutic regimen: Experience from a north Indian tertiary care centre." Clinical Lymphoma Myeloma and Leukemia 22.6 (2022): 416-423.

To arrange a visit or to enquire about any of our products, please feel free to contact us and one of our representatives will be in touch within 24 hours